USPTO serial 98526431
FLEXING OUR MUSCLE
Reviewed by CopyMark Law Group
Status 733Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- IN, SUNG HYUN
- Law office
- —
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with FLEXING OUR MUSCLE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA, US
South San Francisco, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Brett Heavner
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP901 New York Avenue NWWashington, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of cardiovascular, heart and muscle diseases and disorders | ACTIVE | — |
| 044 | Providing information services in the field of cardiovascular, heart and muscle disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of cardiovascular, heart and muscle diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of cardiovascular, heart and muscle diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for cardiovascular, heart and muscle diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular, heart and muscle diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of cardiovascular, heart and muscle disease and conditions; Providing a website featuring educational information in the field of cardiovascular, heart and muscle diseases and conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 28, 2026 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 28, 2026 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 28, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 7, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 6, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 6, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 21, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 19, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 19, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 19, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 20, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 20, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 20, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 20, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 17, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 23, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 23, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 3, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 15, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 30, 2024 | NWAP | NEW APPLICATION ENTERED | — |